Certainly! Here is the content you requested:
WHO,partners support Indonesia to develop path-breaking human health sector plan to address antimicrobial resistance
On 29 February 2024,the World Health Association (WHO),Indonesian ministry of Health,and key partners such as the Asia-Europe Foundation concluded a series of workshops aimed at developing the world’s first human health sector-specific national action plan to address antimicrobial resistance (AMR) based on the WHO people-centred approach.AMR occurs when bacteria, viruses, fungi, and othre microorganisms evolve and become resistant to the drugs designed to kill them, making infections harder to treat and increasing the risk of disease spread, severe illness, and death.
PDF Country case study – Indonesia – World Health Organization
WHO costing and budgeting tool for national action plans on antimicrobial resistance: user guide
Indonesia’s AMR NAP has six strategic objectives:
- Raising awareness and understanding regarding AMR control through effective interaction, education, and training.
- Increasing knowledge and scientific proof through surveillance and research.
- Preventing the incidence of infection (e.g., vaccination, safe food handling, infection prevention and control).
- optimizing the use of antimicrobial agents in human and animal health.
- Enhancing infection treatment and patient safety.
- Ensuring enduring investment in AMR interventions.
Progress towards antimicrobial resistance containment and control in Indonesia
A pilot program to evaluate Indonesia’s antimicrobial susceptibility testing, with critical support from Thailand-based WHO experts.In January 2025, Surabaya’s National Reference Laboratory hosted intensive practical training for 30 technicians, with a focus on quality control.
“The national AMR BSI survey is essential to MoH and WHO efforts to build a sustainable and complete national surveillance system capable of monitoring both drug-susceptible and drug-resistant infections,” said Professor Roderick Salenga, Team Led for Health Systems at WHO Indonesia. “The evidence gathered will directly inform the development of more effective treatment guidelines and public health policies, ensuring that Indonesia not only adapts to AMR’s challenges but actively works to reverse its spread.”
Data collection on AMR BSIs will continue throughout 2025,providing critical insights into resistance patterns and their economic impact across the country. The survey will complement and inform medium and long-term MoH and WHO efforts to tackle AMR, with a focus on strengthening treatment protocols, enhancing hospital preparedness, and shaping responsive public health policies. This will ensure that Indonesia continues to lead globally in the battle against one of humanity’s greatest health and development threats, for stronger health systems and improved patient outcomes.
WHO and Partners Support Indonesia in Developing Groundbreaking Antimicrobial Resistance Plan
On 29 February 2024, the World health Organization (WHO), Indonesian Ministry of Health, and key partners such as the Asia-Europe Foundation concluded a series of workshops. These workshops were aimed at developing the world’s first human health sector-specific national action plan to address antimicrobial resistance (AMR) based on the WHO people-centered approach.
Editor: Can you elaborate on the importance of developing the first human health sector-specific national action plan for AMR?
Guest: Indeed, this is a monumental step forward. By creating a tailored plan for the human health sector, Indonesia is taking a proactive stance in addressing antimicrobial resistance. This plan goes beyond mere reaction to challenges and instead employs a strategy that is deeply rooted in data and community engagement. It focuses on specific measures like surveillance, research, and education, which are critical to halting the spread of resistant microorganisms.
Editor: According to the article, the plan has six strategic objectives. What are the key priorities or goals outlined in these objectives?
Guest: The six strategic objectives provide a complete approach to tackling AMR.First, it aims to raise awareness and understanding through effective education and training.Second, it seeks to increase knowledge and scientific evidence through surveillance and research. Third,it aims to prevent infections by promoting vaccination,safe food handling,and infection prevention and control. Fourth, it focuses on optimizing the use of antimicrobial agents in both human and animal health. Fifth,it enhances global governance and international cooperation to combat AMR. it supports the development and implementation of relevant policies and regulations. These objectives collectively aim to control and reverse antimicrobial resistance.
Editor: How does Indonesia’s AMR national action plan (NAP) differ from other international approaches in this regard?
Guest: Indonesia’s NAP is distinctive because it’s designed to not only adapt to AMR’s challenges but actively works to reverse its spread. This interactive and holistic approach involves all stakeholders from government to healthcare workers and the general public. Additionally, the plan incorporates WHO’s costing and budgeting tools, facilitating better resource allocation and ensuring the sustainability of the interventions.
Editor: Could you discuss the impact of data collection on AMR bloodstream infections (BSIs) and its role in informing medium and long-term public health strategies?
Guest: Data collection on AMR BSIs is vital as it provides critical insights into resistance patterns and their economic impact. This information is invaluable for shaping treatment protocols, enhancing hospital preparedness, and influencing public health policies. By having continuous data, Indonesia can make evidence-based decisions and stay ahead in the global battle against AMR. This effort will also help in improving patient outcomes and strengthening health systems.
Conclusion: Indonesia’s initiative to develop the first human health sector-specific national action plan on antimicrobial resistance is a promising step towards global health security. This plan,powered by strategic objectives and community engagement,not only aims to control but to actively reverse the spread of antimicrobial resistance. By utilizing data-driven approaches and fostering international cooperation, Indonesia is setting a commendable example for other countries in combating one of the most pressing health and development threats of our time.
